Intellia Therapeutics Inc buy Guggenheim
Start price
12.05.25
/
50%
€7.88
Target price
12.05.26
€40.09
Performance (%)
-4.92%
Price
17.12.25
€7.49
Summary
This prediction is currently active. With a performance of -4.92%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 12.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -6.653% | -6.653% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Guggenheim for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Guggenheim from $55.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat